Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $36.68 USD
Change Today -0.35 / -0.95%
Volume 190.4K
OMCL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 2:15 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

omnicell inc (OMCL) Snapshot

Open
$36.94
Previous Close
$37.03
Day High
$36.95
Day Low
$36.49
52 Week High
07/23/15 - $40.80
52 Week Low
08/4/14 - $26.00
Market Cap
1.3B
Average Volume 10 Days
295.1K
EPS TTM
$0.80
Shares Outstanding
36.2M
EX-Date
--
P/E TM
45.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for OMNICELL INC (OMCL)

Related News

No related news articles were found.

omnicell inc (OMCL) Related Businessweek News

No Related Businessweek News Found

omnicell inc (OMCL) Details

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates in two segments, Automation and Analytics, and Medication Adherence. It offers OmniRx, a dispensing system that automates the management and dispensing of medications at the point of use; SinglePointe, a software product that controls medications; AnywhereRN, a software to remotely operate automated dispensing cabinets; Pandora Analytics, a reporting and data analytics tool; Savvy Mobile System, which provides a mobile platform for hospital information systems; OmniLinkRx, a prescription routing system; WorkflowRx, an automated pharmacy storage, retrieval, and packaging system; Central Pharmacy and Satellite Pharmacy Manager, a software for managing inventory in central and satellite pharmacy locations; Controlled Substance Management, a controlled substance inventory management system; and Anesthesia Workstation, a dispensing system for managing anesthesia supplies and medications. The company also provides Omnicell Supply Solution, which automates the management and dispensing of medical and surgical supplies at the point of use; Omnicell Open Supply Solution for remote inventory management; Supply/Rx Combination Solution for managing supplies and medications from the same cabinets; Omnicell Tissue Center that manages the chain of custody for bone and tissue specimens; OptiFlex SS, a module for the perioperative areas; OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas; and OptiFlex MS, a system for managing medical and surgical supplies. In addition, it offers consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.

1,236 Employees
Last Reported Date: 03/30/15
Founded in 1992

omnicell inc (OMCL) Top Compensated Officers

Executive Chairman, Chief Executive Officer a...
Total Annual Compensation: $551.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $302.8K
Chief Administrative Officer, Chief Legal Off...
Total Annual Compensation: $270.2K
Executive Vice President of Strategy and Busi...
Total Annual Compensation: $273.5K
Executive Vice President of Sales and Marketi...
Total Annual Compensation: $322.5K
Compensation as of Fiscal Year 2014.

omnicell inc (OMCL) Key Developments

Omnicell, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Earnings Guidance for the Full Year of 2015

Omnicell, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenues of $112,788,000 compared to $105,052,000 a year ago. Income from operations was $12,424,000 compared to $12,558,000 a year ago. Income before provision for income taxes was $11,952,000 compared to $12,518,000 a year ago. Net income was $8,751,000 or $0.24 per diluted share compared to $7,789,000 or $0.21 per diluted share a year ago. Non-GAAP net income was $10,269,000 or $0.28 per diluted share compared to $11,162,000 or $0.30 per diluted share a year ago. Non-GAAP income from operations was $14,427,000 compared to $16,326,000 a year ago. Non-GAAP adjusted EBITDA was $18,493,000 compared to $19,985,000 a year ago. Non-GAAP Operating income was $25,525,000 compared to $27,432,000 a year ago. For the six months, the company reported total revenues of $229,009,000 compared to $206,816,000 a year ago. Income from operations was $22,803,000 compared to $22,512,000 a year ago. Income before provision for income taxes was $21,814,000 compared to $22,216,000 a year ago. Net income was $15,069,000 or $0.41 per diluted share compared to $13,983,000 or $0.38 per diluted share a year ago. Non-GAAP net income was $21,040,000 or $0.57 per diluted share compared to $20,754,000 or $0.57 per diluted share a year ago. Non-GAAP income from operations was $29,702,000 compared to $30,057,000 a year ago. Non-GAAP adjusted EBITDA was $37,830,000 compared to $37,021,000 a year ago. Non-GAAP Operating income was $25,525,000 compared to $27,432,000 a year ago. The company revised earnings guidance for the full year of 2015. The company expects non-GAAP earnings to be between $1.31 and $1.36 per share, consistent with previous guidance. The company previously expected revenue to be between $495 million and $510 million. The company still expects non-GAAP operating margins to be approximately 14% after absorbing the cost to integrate the acquisitions. The company expects to return to 15% operating margins in 2016 when both acquisitions become accretive to earnings.

Omnicell, Inc. to Report Q2, 2015 Results on Jul 30, 2015

Omnicell, Inc. announced that they will report Q2, 2015 results at 1:30 PM, Pacific Standard Time on Jul 30, 2015

Omnicell, Inc., Q2 2015 Earnings Call, Jul 30, 2015

Omnicell, Inc., Q2 2015 Earnings Call, Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OMCL:US $36.68 USD -0.35

OMCL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Draegerwerk AG & Co KGaA €74.96 EUR +1.45
Fresenius SE & Co KGaA €65.15 EUR +0.166
Hospira Inc $89.53 USD 0.00
Vocera Communications Inc $11.90 USD -0.07
View Industry Companies
 

Industry Analysis

OMCL

Industry Average

Valuation OMCL Industry Range
Price/Earnings 42.6x
Price/Sales 2.8x
Price/Book 3.3x
Price/Cash Flow 41.9x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNICELL INC, please visit www.omnicell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.